National HealthCare Corporation — Cyborg Score 7/10

Strategic Profile

NHC leverages its regional footprint and integrated service model to serve elderly and post-acute care populations. The company operates through two segments—Inpatient and Homecare and Hospice Services—positioning it as a diversified healthcare provider in high-demand senior care markets.

Cyborg Score Rationale

NHC demonstrates stable fundamentals with a 52-week high, solid profitability metrics (7.91% net margin), and consistent dividend payments. The company's regional scale and diversified service offerings provide resilience, though healthcare sector dynamics and regulatory pressures create ongoing headwinds.

Top Insights

• Stock reached new 52-week high at $171.95 in early March 2026, indicating positive market momentum
• Q4 2025 earnings showed $386.51M quarterly revenue with $1.83 EPS, reflecting stable operational performance
• Integrated service model spans inpatient facilities, homecare, hospice, behavioral health, and managed care insurance
• Low beta (0.60) suggests defensive positioning relative to broader equity markets

Named Competitors

• Skilled Nursing & Assisted Living — Large national senior living operator
• Senior Living Services — Senior care facility operator
• Post-Acute Care — Healthcare real estate investor

Recent Developments

• (February 2026) Q4 2025 earnings reported with $386.51M revenue and $1.83 EPS
• (March 2026) Stock hits new 52-week high at $171.95
• (March 2026) Announced quarterly dividend of $0.64 with ex-date March 31, 2026

Open the full interactive National HealthCare Corporation report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.